The table below, based on the 2024 National Health Interview Survey, provides a detailed breakdown of GLP-1 injectable use among adults with diagnosed diabetes
According to Clinical Studies, weight loss from GLP-1 medications such as Ozempic combined with lifestyle changes can result in weight loss up to 25%, but is dependent on the medication, the dose/strength, and the timeline
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ozempic specifically for glycaemic control in adults with type 2 diabetes, either as monotherapy or in combination with other glucose-lowering medicines
Frequently asked questions (FAQs) What is Ozempic
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
Is it possible to inject Wegovy incorrectly